WO2008000777A3 - Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use - Google Patents
Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use Download PDFInfo
- Publication number
- WO2008000777A3 WO2008000777A3 PCT/EP2007/056448 EP2007056448W WO2008000777A3 WO 2008000777 A3 WO2008000777 A3 WO 2008000777A3 EP 2007056448 W EP2007056448 W EP 2007056448W WO 2008000777 A3 WO2008000777 A3 WO 2008000777A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- phenyl
- pharmaceutical use
- pyrazole derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
The present invention provides compounds of formula (I), a process for their preparation, to pharmaceutical compositions comprising the compounds and the preparation of said compositions, to intermediates and to use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation and/or allergic conditions.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0612942A GB0612942D0 (en) | 2006-06-29 | 2006-06-29 | Novel compounds |
GB0612942.3 | 2006-06-29 | ||
GB0625458A GB0625458D0 (en) | 2006-12-20 | 2006-12-20 | Novel compounds |
GB0625458.5 | 2006-12-20 | ||
GB0700077.1 | 2007-01-03 | ||
GB0700077A GB0700077D0 (en) | 2007-01-03 | 2007-01-03 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008000777A2 WO2008000777A2 (en) | 2008-01-03 |
WO2008000777A3 true WO2008000777A3 (en) | 2008-02-07 |
Family
ID=38512590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/056448 WO2008000777A2 (en) | 2006-06-29 | 2007-06-27 | Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008000777A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0611587D0 (en) * | 2006-06-12 | 2006-07-19 | Glaxo Group Ltd | Novel compounds |
CN107072976A (en) | 2014-05-12 | 2017-08-18 | 葛兰素史克知识产权第二有限公司 | The pharmaceutical composition for including Danirixin for treating communicable disease |
WO2021191875A1 (en) | 2020-03-26 | 2021-09-30 | Glaxosmithkline Intellectual Property Development Limited | Cathepsin inhibitors for preventing or treating viral infections |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999057101A1 (en) * | 1998-05-05 | 1999-11-11 | F. Hoffmann-La Roche Ag | Pyrazole derivatives as p-38 map kinase inhibitors |
WO2000032584A2 (en) * | 1998-11-27 | 2000-06-08 | Schering Aktiengesellschaft | Nonsteroidal antiinflammatories |
WO2004071389A2 (en) * | 2003-02-15 | 2004-08-26 | Glaxo Group Limited | Non-steroidal infalmmation inhibitors |
WO2005030213A1 (en) * | 2003-09-24 | 2005-04-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
WO2007000334A1 (en) * | 2005-06-29 | 2007-01-04 | Glaxo Group Limited | Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
-
2007
- 2007-06-27 WO PCT/EP2007/056448 patent/WO2008000777A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999057101A1 (en) * | 1998-05-05 | 1999-11-11 | F. Hoffmann-La Roche Ag | Pyrazole derivatives as p-38 map kinase inhibitors |
WO2000032584A2 (en) * | 1998-11-27 | 2000-06-08 | Schering Aktiengesellschaft | Nonsteroidal antiinflammatories |
WO2004071389A2 (en) * | 2003-02-15 | 2004-08-26 | Glaxo Group Limited | Non-steroidal infalmmation inhibitors |
WO2005030213A1 (en) * | 2003-09-24 | 2005-04-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
WO2007000334A1 (en) * | 2005-06-29 | 2007-01-04 | Glaxo Group Limited | Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
Also Published As
Publication number | Publication date |
---|---|
WO2008000777A2 (en) | 2008-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007144327A3 (en) | Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands | |
WO2009111700A3 (en) | Oxadiazoanthracene compounds for the treatment of diabetes | |
WO2007048801A3 (en) | Sexual desire enhancing medicaments comprising benzimidazolone derivatives | |
MX2010001236A (en) | 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators. | |
WO2007054257A3 (en) | Indene derivatives, their preparation and use as medicaments | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
NO20084328L (en) | New connections | |
WO2009069032A3 (en) | Novel glucocorticoid receptor agonists | |
WO2010066684A3 (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
GB0620385D0 (en) | Novel compounds | |
MX2011012122A (en) | Thiophene derivatives. | |
MX2012002179A (en) | Heterocyclic oxime compounds. | |
WO2007009723A3 (en) | Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments | |
WO2009109618A3 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 | |
WO2007093880A3 (en) | Novel pyrone-indole derivatives and process for their preparation | |
WO2009109616A8 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 | |
WO2009030952A3 (en) | Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway | |
WO2007135026A3 (en) | Substituted pteridines as therapeutic agents | |
WO2011006935A3 (en) | Tetrazole derivatives | |
GEP20135806B (en) | Lactams as beta secretase inhibitors | |
WO2008143649A3 (en) | Novel oxazolidinone compounds as antiinfective agents | |
WO2009003719A3 (en) | Indane-amine derivatives, their preparation and use as medicaments | |
WO2007098964A3 (en) | Pyrrazole derivatives as sigma receptors antagonists | |
WO2008116663A3 (en) | Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments | |
WO2011009714A3 (en) | Benzoquinolizinium salt derivatives as anticancer agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07765684 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07765684 Country of ref document: EP Kind code of ref document: A2 |